Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Severe Hypophosphatemia in Patients with Cancer Following IV Iron Treatment: Results from a Large Comparative Trial

Ralph V. Boccia, MD, Naomi V Dahl, PharmD, William E Strauss, MD

Blood (2019) 134 (Supplement_1): 2236.

https://doi.org/10.1182/blood-2019-126149

Published: 2019

Journal Articles

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Rafael Fonseca, MD, May Hagiwara, PhD, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Jacqueline Buchanan, Thomas Delea, MBA

Blood (2019) 134 (Supplement_1): 2211.

https://doi.org/10.1182/blood-2019-123743

Published: 2019

Journal Articles

Too big for flow

Carole Almire, Nicolas Chapuis

Blood (2019) 134 (6): 576.

https://doi.org/10.1182/blood.2019001172

Published: 2019

Journal Articles

Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis

Janik Engelmann, Isabel Ben Batalla, PhD, Hanna Taipaleenmäki, PhD, Kristoffer Riecken, PhD, Victoria Gensch, Sarina Paesler, Nikolaus Berenbrok, Maria Elena Vargas, Jonas Waizenegger, MD, Boris Fehse, PhD, Klaus Pantel, MD, PhD, Ihab S Darwish, PhD, Somasekhar Bhamidipati, PhD, Esteban Masuda, PhD, Carsten Bokemeyer, MD, PhD, Eric Hesse, MD, PhD, Sonja Loges, MD, PhD

Blood (2018) 132 (Supplement 1): 1922.

https://doi.org/10.1182/blood-2018-99-118273

Published: 2018

Journal Articles

PTHrP May Contribute to Cachexia Accompanying Multiple Myeloma Bone Disease

Attaya Suvannasankha, MD, Colin Crean, BS, Isaac Carrera Ochoa, G David Roodman, MD PhD, John Chirgwin, PhD

Blood (2018) 132 (Supplement 1): 4450.

https://doi.org/10.1182/blood-2018-99-115680

Published: 2018

Journal Articles

Burden of Disease Progression in Patients with Multiple Myeloma Who Have Received at Least One Line of Therapy in the US

May Hagiwara, PhD, Thomas Delea, MBA, MSIA, Sumeet Panjabi, PhD, Emre Yucel, PhD MSc, MBA, BSPharm, Rafael Fonseca, MD

Blood (2018) 132 (Supplement 1): 4754.

https://doi.org/10.1182/blood-2018-99-117230

Published: 2018

Journal Articles

Patchy hematopoiesis mimicking bone metastasis

A. C. Cornelisse, Peter A. W. te Boekhorst

Blood (2018) 132 (15): 1626.

https://doi.org/10.1182/blood-2018-06-856823

Published: 2018

Journal Articles

The Exosomes-Derived EGFR Ligand Amphiregulin (AREG) Is a New Pro-Osteoclastogenic Factor in Multiple Myeloma

Emanuela Vicario, PhD, Stefania Raimondo, PhD, Laura Saieva, PhD, Federica Costa, PhD, Vincenza Tinnirello, Fabrizio Accardi, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD, Riccardo Alessandro, PhD

Blood (2017) 130 (Supplement 1): 1776.

https://doi.org/10.1182/blood.V130.Suppl_1.1776.1776

Published: 2017

Journal Articles

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

Valery J Li, MD, Yimei Miao, BS, Cy Wilkins, MD, Gerald A. Soff, MD

Blood (2017) 130 (Supplement 1): 2324.

https://doi.org/10.1182/blood.V130.Suppl_1.2324.2324

Published: 2017

Journal Articles

The Combination of Radium-223 Dichloride and Bortezomib Effectively Reduces Tumor Burden and Lesion Area in the Syngeneic, Systemic 5TGM1 Multiple Myeloma Mouse Model

Mari Suominen, Tiina Kähkönen, Jenni Mäki-Jouppila, Jukka P Rissanen, Anniina Luostarinen, Katja M Fagerlund, Birgitta Sjöholm, Esa Alhoniemi, Sanna Kakonen, PhD, Gerhard Siemeister, Dominik Mumberg, Jussi M Halleen, Karl Ziegelbauer, Arne Scholz

Blood (2017) 130 (Supplement 1): 1802.

https://doi.org/10.1182/blood.V130.Suppl_1.1802.1802

Published: 2017

Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens

Blood (2017) 130 (Supplement 1): 5165.

https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165

Published: 2017

Journal Articles

Risk Factors of Central Nervous System Involvement in Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Mahmoud Husni Hajyousef, MD, Associate Professor, Tariq Zuheir Kewan, MD, Deeb Jamil Zahran, MD, Sohaib Mahmoud Al-Khatib, MD

Blood (2017) 130 (Supplement 1): 5227.

https://doi.org/10.1182/blood.V130.Suppl_1.5227.5227

Published: 2017

Journal Articles

Myeloma Cells Induce High Level of TAF12 Expression in Bone Marrow Stromal Cells, Resulting in Increased Osteoclastogenesis and Myeloma Cell Growth in Response to 1,25(OH) 2 D 3

Yasuhisa Ohata, MD PhD, John M Chirgwin, PhD, Jolene J Windle, PhD, G. David Roodman, MD PhD, Noriyoshi Kurihara, DDS, PhD

Blood (2016) 128 (22): 4421.

https://doi.org/10.1182/blood.V128.22.4421.4421

Published: 2016

Journal Articles

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Sujeetha A. Rajakumar, MSc, Eniko Papp, PhD, Ildiko Grandal, MSc, Daniele Merico, PhD, Careesa C. Liu, MSc, Bedilu Allo, PhD, Lucia Zhang, Marc Grynpas, PhD, Mark D. Minden, MD PhD, Johann K. Hitzler, MD, Cynthia J. Guidos, PhD, Jayne S. Danska, PhD

Blood (2016) 128 (22): 908.

https://doi.org/10.1182/blood.V128.22.908.908

Published: 2016

Journal Articles

Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow

Mikhail Kolonin, PhD, Anna Sergeeva, PhD, Daniela Staquicini, PhD, Jeffrey J. Molldrem, MD, Renata Pasqualini, PhD, Wadih Arap, MD PhD

Blood (2016) 128 (22): 1025.

https://doi.org/10.1182/blood.V128.22.1025.1025

Published: 2016

Journal Articles

Use and Patterns of Supportive Care Among Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer, Colorectal Cancer, Lung Cancer, or Non-Hodgkin's Lymphoma in US Clinical Practice

Derek Weycker, PhD, Amanda Silvia, BS, Kathryn Richert-Boe, MD MPH, Mark Bensink, PhD MS, James O. Brady, MD, Lois Lamerato, PhD, Heather Lipkovich, MPH, Ahmad Daniyal Siddiqui, MD, David Chandler, PhD MBA

Blood (2016) 128 (22): 5909.

https://doi.org/10.1182/blood.V128.22.5909.5909

Published: 2016

Journal Articles

Regulation of Osteoblast Function in Myeloma Bone Disease By Semaphorin 4D

Attaya Suvannasankha, MD, Colin D Crean, Douglas R Tompkins, Jesus Delgado-Calle, PhD, Teresita M Bellido, PhD, G. David Roodman, MD PhD, John M Chirgwin, PhD

Blood (2016) 128 (22): 4439.

https://doi.org/10.1182/blood.V128.22.4439.4439

Published: 2016

Journal Articles

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

Eiran Warner, MD BA, Catherine Broome, MD

Blood (2016) 128 (22): 3843.

https://doi.org/10.1182/blood.V128.22.3843.3843

Published: 2016

Journal Articles

A case of multiple myeloma mimics: extensive bone metastasis of hepatocellular carcinoma without liver mass

Huifei Liu, Yang O Huh

Blood (2016) 127 (3): 368.

https://doi.org/10.1182/blood-2015-10-677880

Published: 2016

Journal Articles

Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions

Ombretta Annibali, MDPhD, Maria Teresa Petrucci, MD, Daniele Santini, MD, Elisabetta Lisi, PhD, MArco Mariani, Francesco Pisani, Member, ID:, 1012314, Velia Bongarzoni, Olga Venditti, MD, Angela Rago, Elisabetta Cerchiara, MD, Alessia Fiorini, MD, Luca Franceschini, MD, Stefano Felici, MD, MArco Russano, MD, Francesco PAntano, MD, Giuseppe Avvisati, MD PhD

Blood (2015) 126 (23): 5359.

https://doi.org/10.1182/blood.V126.23.5359.5359

Published: 2015

NARROW

Severe Hypophosphatemia in Patients with Cancer Following IV Iron Treatment: Results from a Large Comparative Trial

Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US

Too big for flow

Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis

PTHrP May Contribute to Cachexia Accompanying Multiple Myeloma Bone Disease

Burden of Disease Progression in Patients with Multiple Myeloma Who Have Received at Least One Line of Therapy in the US

Patchy hematopoiesis mimicking bone metastasis

The Exosomes-Derived EGFR Ligand Amphiregulin (AREG) Is a New Pro-Osteoclastogenic Factor in Multiple Myeloma

Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies

The Combination of Radium-223 Dichloride and Bortezomib Effectively Reduces Tumor Burden and Lesion Area in the Syngeneic, Systemic 5TGM1 Multiple Myeloma Mouse Model

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Risk Factors of Central Nervous System Involvement in Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Myeloma Cells Induce High Level of TAF12 Expression in Bone Marrow Stromal Cells, Resulting in Increased Osteoclastogenesis and Myeloma Cell Growth in Response to 1,25(OH) 2 D 3

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Neutrophil-Secreted Proteinase 3 Mediates Metastasis of Prostate Cancer Cells Expressing RAGE to the Bone Marrow

Use and Patterns of Supportive Care Among Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer, Colorectal Cancer, Lung Cancer, or Non-Hodgkin's Lymphoma in US Clinical Practice

Regulation of Osteoblast Function in Myeloma Bone Disease By Semaphorin 4D

Complement Inhibition with C1 Esterase Inhibitor Allowed Successful Transfusion of Antigen Mismatched Packed Red Blood Cells : A Case Report

A case of multiple myeloma mimics: extensive bone metastasis of hepatocellular carcinoma without liver mass

Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only